Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) Short Interest Declined By 10.29%

June 29, 2018 - By Ronnie Lemelle

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) reported a decrease of 10.29% in short interest. In June was announced XTNT’s total 146,500 short interest by FINRA. The 163,300 previous shares are down with 10.29%. With Average volume 19,500, XTNT’s previous position will take 8 days to restore. 1.26% is Xtant Medical Holdings Inc float short.

Lastly it traded at $5.6.Since June 29, 2017 it’s 19.38% down thus uptrending. The stock outperformed the S&P 500 by 6.81%.

Xtant Medical Holdings, Inc. develops, makes, and markets regenerative medicine products and devices in the United States and internationally.The firm is valued at $73.23 million. The Company’s biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system.Currently it has negative earnings. The firm also provides BacFast HD facet stabilization dowels; OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; hMatrix dermal scaffold, an acellular matrix made from donated human dermal tissue that is used to replace a patient??s damaged tissue; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.